Capital Group Investment Management Pte. Ltd. Ascendis Pharma A/S Transaction History
Capital Group Investment Management Pte. Ltd.
- $503 Million
- Q4 2024
A detailed history of Capital Group Investment Management Pte. Ltd. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Capital Group Investment Management Pte. Ltd. holds 3,609 shares of ASND stock, worth $519,984. This represents 0.1% of its overall portfolio holdings.
Number of Shares
3,609Holding current value
$519,984% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding ASND
# of Institutions
236Shares Held
59.6MCall Options Held
108KPut Options Held
234K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.46 Billion22.55% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.53MShares$797 Million3.52% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.1MShares$735 Million10.24% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.45MShares$641 Million0.98% of portfolio
-
Janus Henderson Group PLC London, X04.38MShares$631 Million0.32% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $8.04B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...